Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
Publication|Videos|October 3, 2024

Parexel’s FSP: Evolving With Your Needs Now and in the Future

Author(s)PAREXEL

Jenny Denney, EVP, Head of FSP Clinical and Biometrics at Parexel, discusses current transformations in the industry in addition to how Parexel, as the landscape shifts, supports clients with proper models and infrastructure from a functional service provider (FSP) perspective.

• A one-size-fits-all model no longer exists. Because of this, Parexel's models are flexible and agile, designed to adapt to customer needs and their shifting pipeline priorities—and whatever challenges they face.
• One of Parexel's key differentiators is its people-centric approach. The company does everything with heart. While technology plays a significant role in transforming the industry, it is ultimately powered by Parexel's dedicated people.
• Parexel has a remarkable global infrastructure that spans across numerous countries. This infrastructure allows it to provide real-time connectivity and ensures it can find the right people in the right place at the right time, which is essential for the success of the FSP model.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.